BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 8019107)

  • 1. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
    Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
    Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
    Marek J; Zivný J; Srámková J; Kucera E; Kobilková J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():110-7. PubMed ID: 6242681
    [No Abstract]   [Full Text] [Related]  

  • 4. [Disappearance of the radiographic image of a macroprolactinoma after treatment with bromocriptine].
    Forsbach G; Olivares F; Vázquez J; Güitrón A
    Ginecol Obstet Mex; 1998 Apr; 66():170-2. PubMed ID: 9617019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amenorrhea, galactorrhea, and hyperprolactinemia.
    Magyar DM
    J Am Osteopath Assoc; 1985 Jun; 85(6):375-80. PubMed ID: 3905728
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term follow-up of women with amenorrhea-galactorrhea treated with bromocriptine.
    Tartagni M; Nicastri PL; Diaferia A; Di Gesù I; Loizzi P
    Clin Exp Obstet Gynecol; 1995; 22(4):301-6. PubMed ID: 8777784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinemia. Its relation to galactorrhea, amenorrhea, pituitary tumor and its management.
    Ge QS; Xu L; Wang HL; Gu CX; Lin SQ; Xu YD; Yu KM; Xie YZ; Shi YF; Zang X
    Chin Med J (Engl); 1985 Aug; 98(8):543-50. PubMed ID: 3937678
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of galactorrhea-amenorrhea.
    De Leon FD
    Am Fam Physician; 1985 Dec; 32(6):121-4. PubMed ID: 4072865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY; Jarrett JC; Choe JK
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.
    Gheri RG; Boddi W; Ammannati F; Olivotto J; Nozzoli C; Franchi A; Bordi L; Luisi ML; Mennonna P
    J Endocrinol Invest; 1997 Apr; 20(4):240-4. PubMed ID: 9211134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
    Meduri M; Deodato M; Bramanti P; Volpe A; Grasso A; Di Perri R
    Acta Neurol (Napoli); 1980 Feb; 2(1):15-22. PubMed ID: 7190350
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of lysenyl-forte and methergoline in the therapy of hyperprolactinemic hypogonadism].
    Mel'nichenko GA; Dedov II; Gitel' EP; Ilovaĭskaia IA
    Probl Endokrinol (Mosk); 1991; 37(2):20-2. PubMed ID: 1857694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.
    Boulanger CM; Mashchak CA; Chang RJ
    Fertil Steril; 1985 Oct; 44(4):532-5. PubMed ID: 4054327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bromocriptine monotherapy of a prolactinoma causing erectile dysfunction].
    López Cubillana P; Hita Rosino E; Asensio Egea L; Rigabert Montiel M; Hita Villaplana G; Server Pastor G; Server Falgás G
    Arch Esp Urol; 1997 Jun; 50(5):526-8. PubMed ID: 9382597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ropinirole for the Treatment of Hyperprolactinemia: A Dose-Escalation Study of Efficacy and Tolerability.
    Heneghan LJ; Tsang A; Dimino C; Khandji AG; Panigrahi SK; Page-Wilson G
    J Clin Endocrinol Metab; 2024 Jan; 109(2):e667-e674. PubMed ID: 37715962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic evaluation of hyperprolactinemia.
    Biller BM
    J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Headache, hyperprolactinemia, and prolactinomas.
    Strebel PM; Zacur HA; Gold EB
    Obstet Gynecol; 1986 Aug; 68(2):195-9. PubMed ID: 3737035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Persisting suppression of hyperprolactinemia after bromcriptine withdrawal].
    Drobnjak P; Simunić V; Puharić I; Suchanek E
    Jugosl Ginekol Opstet; 1982; 22(1-2):31-4. PubMed ID: 7132424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.